ExploreWatchlistsPricing
  1. JP-listed companies
  2. ROHTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Accounts payable

ROHTO PHARMACEUTICAL CO.,LTD. (4527)

Market cap
¥566.8B
P/E ratio
15.7x
Rohto Pharmaceutical manufactures and sells eye care, skin care, and oral medications globally through its subsidiaries including Mentholatum brands.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndAccounts payable (Million JPY)YoY (%)
Mar 31, 202620,937+9.91%
Mar 31, 202519,050+12.12%
Mar 31, 202416,991+6.03%
Mar 31, 202316,025+17.31%
Mar 31, 202213,660+42.25%
Mar 31, 20219,603-15.20%
Mar 31, 202011,324+2.90%
Mar 31, 201911,005-9.03%
Mar 31, 201812,098+26.11%
Mar 31, 20179,593-2.07%
Mar 31, 20169,796-3.53%
Mar 31, 201510,154

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat